Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.
Schaefer B, Würtinger P, Finkenstedt A, Braithwaite V, Viveiros A, Effenberger M, Sulzbacher I, Moschen A, Griesmacher A, Tilg H, Vogel W, Zoller H.
Schaefer B, et al.
PLoS One. 2016 Dec 1;11(12):e0167146. doi: 10.1371/journal.pone.0167146. eCollection 2016.
PLoS One. 2016.
PMID: 27907058
Free PMC article.